Medohar Guggulu in Medoroga (dyslipidaemia with central obesity)
A randomised controlled trial of Medohar Guggulu with Udvartana versus lifestyle modification in Medoroga presenting as dyslipidaemia with central obesity
- Sponsor
- All India Institute of Ayurveda (intramural)
- Principal investigator
- Dr. G. Pillai · Associate Professor, Swasthavritta
- Condition studied
- Dyslipidaemia with central obesity (Medoroga)
- Design
- Randomised, parallel group, open label
- Intervention
- Medohar Guggulu 1 g twice daily + Udvartana, 20 weeks
- Comparator
- Structured lifestyle modification
Study lifecycle
Protocol through close-out. Completed stages are filled, the current stage pulses.
Protocol
06 Jun 2026
EC Approval
26 Jun 2026
CTRI Registration
16 Jul 2026
Site Activation
05 Aug 2026
currentScreening
—
Enrolment
—
Follow-up
—
Close-out
—
Enrolment against target
2 of 20 participants (10%)
Screening funnel
Screened through to follow-up completion
Site-wise enrolment
Real institutes from the NPvCC network
| Site | Tier | HFR id | Enrolled | Share |
|---|---|---|---|---|
| All India Institute of Ayurveda, New DelhiNew Delhi · Ayurveda | NPvCC | IN0710000123 | 2 | |
| Institute of Teaching and Research in Ayurveda (ITRA)Jamnagar · Ayurveda | IPvC | IN2410000318 | 0 |
Consent tracking
Versioned, specific and withdrawable — the DPDP requirement
Participants consented
2
Current consent version
v1.0
Re-consent required
0
Withdrawn
0
Protocol deviations
2 open of 2 recorded
Randomisation
Allocation envelope opened out of sequence at satellite site
DEV-MED-01 · 10 Aug 2026
Study drug
Dispensing log not reconciled at end of month
DEV-MED-02 · 03 May 2026
Data queries
0 open · 0 answered · 1 closed
Birth date inconsistent with the age recorded at screening — please confirm.
Demographics · BRTHDTC · AIIA-MED-DEL-001
Enrolled participants
De-identified by construction — identifier, sex and age only. No name, address or contact data exists in this system.
| USUBJID | Site | Status | Sex | Age | Planned arm | Consent (RFICDTC) | Ref. start (RFSTDTC) | Visits |
|---|---|---|---|---|---|---|---|---|
| AIIA-MED-DEL-001 | DEL | on-study-intervention | F | 44 | Comparator arm | 2026-06-06 | 2026-06-10 | 3/8 |
| AIIA-MED-DEL-002 | DEL | withdrawn | M | 30 | Interventional arm | 2026-06-07 | 2026-06-11 | 8/8 |
1 adverse event recorded on this study — open in Pharmacovigilance